Skip to main content
Premium Trial:

Request an Annual Quote

Biogemma Licenses Evogene's Corn Genes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biogemma has licensed rights to genes from Evogene that it will use to develop corn hybrids with improved yield and drought tolerance, Evogene said today.

The corn lines Paris-based Biogemma will develop under the worldwide, exclusive agreement include genes that the companies evaluated under a collaboration agreement that was started in 2006. Biogemma and Evogene validated corn lines incorporating these genes through field trials in the US and in Israel over the past two years.

"Improved plant yield and drought tolerance are perhaps the most critical needs in today's worldwide agriculture, and as such are key targets for Evogene's ag-bio trait program," Ofer Haviv, Evogene's president and CEO, said in a statement.

Rehovot, Israel-based Evogene's core platform uses computational technologies for gene discovery and high-throughput systems for gene validation.

Financial terms of the agreement were not released.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more